Matthew Bogyo

Professor, Department of Pathology Stanford University.

[Matthew Bogyo @mbogyo]

@VergentBio Congrats to Vergent! This is exciting to see the probe make it into the final stages of clinical trials.

[Vergent Bioscience @VergentBio]

#News: Vergent Bioscience has initiated VISUALIZE 2, a Phase 3 pivotal study evaluating abenacianine (VGT-309) for tumor visualization during lung cancer surgery.

Read more: https://t.co/4vlwFbILNm

#OncologyInnovation #ClinicalResearch

[Matthew Bogyo @mbogyo]

Thrilled to be speaking at the McCaig International Research Conference on #Osteoarthritis, March 11–13, 2026 in Kananaskis, Alberta 🇨🇦.
Trainee abstract submissions open until Oct 31, 2025!
Learn more
#McCaig2026 #BoneAndJointHealth

https://t.co/rRDv3JHEP9

[Matthew Bogyo @mbogyo]

@janeliaconf This meeting is going to be lit!

[Janelia Conferences @janeliaconf]

📢 Announcing ChemTools 2026!

This meeting will focus on:

🧪Platforms & tools for analyzing cell/tissue networks
⚡ Methods to perturb biological networks
🔍Applications that yield new insights

🛏️ Lodging + meals covered

➡️ Apply by Dec 5 @ https://t.co/qlhXkuUEZj

@HHMINews @jenn_prescher @ZevGartner @mbogyo

[Matthew Bogyo @mbogyo]

Great collaboration with @derda_lab @RatmirDerda just posted to bioRxiv. Check out how to best incorporate electrophiles into cyclic peptides to generate covalent inhibitors. https://t.co/nCncmTltyO

[Matthew Bogyo @mbogyo]

Our work identifying new covalent inhibitors of Staphylococcus aureus serine hydrolyses from fragment libraries is out! great work by
@tulsiupadhyay.bsky.social and our many collaborators, including @christianslentz.bsky.social, @mfellnerlab.bsky.social.
https://t.co/D0zrFe95Hz

[Matthew Bogyo @mbogyo]

Another big publication from @sijiewang.bsky.social this week. Check out our efforts to use mRNA display to screen for covalent binding inhibitors of Staphylococcus aureus serine hydrolases. https://t.co/jpgFagjqeV

[Matthew Bogyo @mbogyo]

Amazing work by @sijiewang.bsky.social and our collaborators is out in JACS today. Interested in covalent inhibitors of protein-protein interactions? Check it out. https://t.co/7Ww5sqFLhE

[Cell Chemical Biology @CellChemBiol]

Covalent targeting of splicing in T cells by Kevin A. Scott, Hiroyuki Kojima, Nathalie Ropek, Ekaterina V. Vinogradova @katenokv and colleagues at @RockefellerUniv @TPCB_NYC @WeillCornell @MSKCancerCenter @scrippsresearch https://t.co/UBl0FU7h0l

[Matthew Bogyo @mbogyo]

This work is exciting because increased proteolysis in the gut has been shown to be associated with IBD but no specific proteases have been identified. This new protease could be a viable target for new therapeutics that can control pain and inflammation in many types of IBDs.

[Matthew Bogyo @mbogyo]

Excited to report our studies that identified a new serine protease secreted by the gut microbe Bacteroides fragilis that regulates pain and inflammation through PAR2 activation. Check it out!https://t.co/Ph4YGvrrC8

[Matthew Bogyo @mbogyo]

This is the result of a project initiated by my super talented former postdoc Markus Lakemeyer @MLakeme and a collaboration with Nigel Bunnett’s lab at NYU. Outstanding work by many people including Alan Lomax at Queen’s University in Canada, Kristyna Blazkova and Rocco Latorre.

[Stanford Office of Technology Licensing (OTL) @StanfordOTL]

👀“Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery”
This molecule was developed in Matthew Bogyo’s Stanford lab! @VergentBio @mbogyo

[Matthew Bogyo @mbogyo]

These serine hydrolases are unique to Staphylococcus bacteria and we think play important roles in mobilization of lipids for processes such as biofilm formation. These new compounds will help us to further dissect their functions.

[Matthew Bogyo @mbogyo]

Check out our latest work identifying covalent fragments as inhibitors of the Fph serine hydrolases in S. aureus. Great work from @TulsiUpadhyay5 and our many collaborators. https://t.co/ZNaPo79BW9

[Matthew Bogyo @mbogyo]

Just got started on BlueSky Social. Come follow me there. @mbogyo.bsky.social

[Matthew Bogyo @mbogyo]

@shrma_h Thanks. It was a fun trip and a nice city and University.

[Matthew Bogyo @mbogyo]

Enjoying seeing my colleague’s @CarolynBertozzi Textbook and peanut butter here at the Nobel Museum in Stockholm.